| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,750,000 | 4,502,000 | 7,312,000 | 6,744,000 | | Cost of Revenue | 3,007,000 | 3,831,000 | 5,752,000 | 5,497,000 | | | Gross Profit | (257,000) | 671,000 | 1,560,000 | 1,247,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 160,000 | 268,000 | 44,000 | 171,000 | | Non Recurring | (97,000) | (260,000) | (6,000) | 9,000 | | Others | 158,000 | 141,000 | 195,000 | 113,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (478,000) | 522,000 | 1,327,000 | 954,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (35,000) | 18,000 | (6,000) | 17,000 | | Earnings Before Interest And Taxes | (513,000) | 540,000 | 1,321,000 | 971,000 | | Interest Expense | 36,000 | 41,000 | 40,000 | 42,000 | | Income Before Tax | (549,000) | 499,000 | 1,281,000 | 929,000 | | Income Tax Expense | (110,000) | 201,000 | 339,000 | 255,000 | | Minority Interest |
-
| (8,000) | (23,000) | (6,000) | | | | Net Income From Continuing Ops | (439,000) | 290,000 | 919,000 | 668,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (439,000) | 290,000 | 919,000 | 668,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($439,000) | $290,000 | $919,000 | $668,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
